Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study

Introduction––Serum pepsinogen tests for gastric cancer screening have been debated for decades. We assessed the performance of two pepsinogen assays with or without gastrin-17 for the detection of different precancerous lesions alone or as a composite endpoint in a Latvian cohort. Methods––Within t...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles, Claudia, Rudzite, Dace, Polaka, Inese, Sjomina, Olga, Tzivian, Lilian, Kikuste, Ilze, Tolmanis, Ivars, Vanags, Aigars, Isajevs, Sergejs, Liepniece-Karele, Inta, Razuka-Ebela, Danute, Parshutin, Sergej, Murillo, Raul, Herrero, Rolando, Young Park, Jin, Leja, Marcis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325279/
https://www.ncbi.nlm.nih.gov/pubmed/35885649
http://dx.doi.org/10.3390/diagnostics12071746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325279/
https://www.ncbi.nlm.nih.gov/pubmed/35885649
http://dx.doi.org/10.3390/diagnostics12071746

Ejemplares similares